SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 68 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $52,000 | -63.1% | 2,256 | -62.2% | 0.00% | – |
| Q4 2020 | $141,000 | +176.5% | 5,961 | +95.6% | 0.00% | – |
| Q3 2020 | $51,000 | -16.4% | 3,048 | -23.1% | 0.00% | – |
| Q2 2020 | $61,000 | +238.9% | 3,962 | +109.9% | 0.00% | – |
| Q1 2020 | $18,000 | -56.1% | 1,888 | -59.6% | 0.00% | – |
| Q4 2019 | $41,000 | +41.4% | 4,677 | +20.4% | 0.00% | – |
| Q3 2019 | $29,000 | -19.4% | 3,885 | +1.6% | 0.00% | – |
| Q2 2019 | $36,000 | +3500.0% | 3,824 | +1923.3% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 189 | +96.9% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 96 | -8.6% | 0.00% | – |
| Q2 2018 | $1,000 | -99.4% | 105 | -99.1% | 0.00% | – |
| Q2 2017 | $158,000 | – | 11,329 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $24,631,000 | 16.36% |
| Kynam Capital Management, LP | 2,272,915 | $54,618,000 | 11.51% |
| Frazier Life Sciences Management, L.P. | 3,412,838 | $82,010,000 | 6.32% |
| Foresite Capital Management IV, LLC | 690,000 | $16,581,000 | 5.33% |
| Paradigm Biocapital Advisors LP | 1,085,142 | $26,076,000 | 3.48% |
| ACUTA CAPITAL PARTNERS, LLC | 324,614 | $7,800,000 | 3.36% |
| COMMODORE CAPITAL LP | 738,110 | $17,737,000 | 2.85% |
| SPHERA FUNDS MANAGEMENT LTD. | 822,696 | $19,769,000 | 2.74% |
| Avidity Partners Management LP | 5,586,900 | $134,253,000 | 2.73% |
| HealthCor Management, L.P. | 859,240 | $20,648,000 | 2.58% |